HDL cholesterol: metabolic pathways and drug developments. Fifth Annual International Conference of the Knowledge Foundation. March 8-9, 2004, Cambridge, MA, USA.
Scriabine
Alexander
A
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000378:metabolism*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy / Q000378:metabolism
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL